Androderm TRT: Metabolic Benefits in Hypogonadal US Men with Type 2 Diabetes
Reading Time: 2 minutesIntroduction Hypogonadism, characterized by low serum testosterone levels, is prevalent among American males with type 2 diabetes mellitus (T2DM), affecting up to 50% of this demographic according to data from the National Health and Nutrition Examination Survey (NHANES). This endocrine deficiency exacerbates insulin resistance, visceral adiposity, and dyslipidemia, core components of the metabolic syndrome. Androderm, a transdermal testosterone patch delivering... Read more »
